Company Filing History:
Years Active: 2008
Title: Eri Hashimoto: Innovator in Cancer Diagnostics
Introduction
Eri Hashimoto is a prominent inventor based in Ibaraki, Japan. She has made significant contributions to the field of cancer diagnostics through her innovative research and development. Her work focuses on the creation of antibodies that can detect specific ligands associated with cancer.
Latest Patents
Eri Hashimoto holds a patent for an antibody that specifically reacts with the N-terminal or C-terminal partial peptide of the TGR23-2 ligand. This invention is particularly useful in detecting and quantifying the TGR23-2 ligand. Furthermore, it serves as a potential agent for preventing and treating cancer, as well as a diagnostic tool.
Career Highlights
Eri Hashimoto is currently employed at Takeda Chemical Industries, Ltd., where she continues to advance her research in the field of biomedicine. Her dedication to innovation has positioned her as a key player in the development of new diagnostic methods for cancer.
Collaborations
Eri has collaborated with notable colleagues, including Hirokazu Matsumoto and Masaaki Mori, to further enhance her research efforts and contribute to the scientific community.
Conclusion
Eri Hashimoto's work exemplifies the impact of innovative research in the medical field, particularly in cancer diagnostics. Her contributions are paving the way for new advancements that could significantly improve patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.